Intranasal Insulin for Weight Management During Smoking Cessation

Summary

This FDA-approved (IND# 120700) study will evaluate efficacy of intranasal insulin in reducing snack intake and reducing postprandial free fatty acid levels in abstinent smokers.

Timeline

Start

2014-07

Primary completion

2016-05

Completion

2016-05

Drugs

Indications